183 related articles for article (PubMed ID: 27699446)
1. CALR-mutated primary myelofibrosis evolving to chronic myeloid leukemia with both CALR mutation and BCR-ABL1 fusion gene.
Diamond JM; de Almeida AM; Belo HJ; da Costa MP; Cabeçadas JM; Abecasis MM
Ann Hematol; 2016 Dec; 95(12):2101-2104. PubMed ID: 27699446
[No Abstract] [Full Text] [Related]
2. Detection of CALR Mutation in Clonal and Nonclonal Hematologic Diseases Using Fragment Analysis and Next-Generation Sequencing.
Gardner JA; Peterson JD; Turner SA; Soares BL; Lancor CR; Dos Santos LL; Kaur P; Ornstein DL; Tsongalis GJ; de Abreu FB
Am J Clin Pathol; 2016 Oct; 146(4):448-55. PubMed ID: 27686171
[TBL] [Abstract][Full Text] [Related]
3. The first report of chronic myelogenous leukemia with e19a2 micro-BCR/ABL1 presenting with massive myelofibrosis.
Kim HY; Park S; Kim SH; Kim HJ
Blood Cells Mol Dis; 2017 Jun; 65():68-70. PubMed ID: 28571780
[No Abstract] [Full Text] [Related]
4. Rare Case of Accelerated-Phase Chronic Myeloid Leukemia Diagnosed During Treatment for JAK2 V617F-Positive Primary Myelofibrosis.
Ryu J; Chu D; Park B; Kim M; Cho YU; Hwang SH; Jang S; Seo EJ; Lee JH; Park CJ
Lab Med; 2022 Nov; 53(6):e140-e144. PubMed ID: 35243502
[TBL] [Abstract][Full Text] [Related]
5. Co-occurrence of BCR-ABL1-positive chronic myeloid leukaemia and CALR-mutated essential thrombocythaemia.
da Costa VEF; de Oliveira RD; Traina F; Chahud F; Palma LC; de Figueiredo-Pontes LL
Br J Haematol; 2020 Feb; 188(3):e21-e23. PubMed ID: 31681999
[No Abstract] [Full Text] [Related]
6. A CALR mutation preceding BCR-ABL1 in an atypical myeloproliferative neoplasm.
Cabagnols X; Cayuela JM; Vainchenker W
N Engl J Med; 2015 Feb; 372(7):688-90. PubMed ID: 25671272
[No Abstract] [Full Text] [Related]
7. Secondary chronic myeloid leukemia in a patient with CALR and ASXL1-mutated primary myelofibrosis.
Sobieralski P; Bieniaszewska M; Leszczyńska A; Żuk M; Wasąg B; Zaucha JM
Int J Hematol; 2022 Sep; 116(3):442-445. PubMed ID: 35429330
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetic evaluation of myeloproliferative neoplasms.
Azzato EM; Bagg A
Int J Lab Hematol; 2015 May; 37 Suppl 1():61-71. PubMed ID: 25976962
[TBL] [Abstract][Full Text] [Related]
9. CALR-mutated essential thrombocythemia evolving to chronic myeloid leukemia with coexistent CALR mutation and BCR-ABL translocation.
Bonzheim I; Mankel B; Klapthor P; Schmidt J; Hinrichsen T; Wachter O; Fend F; Quintanilla-Martinez L
Blood; 2015 Apr; 125(14):2309-11. PubMed ID: 25838280
[No Abstract] [Full Text] [Related]
10. Thrombocytosis and STAT5 activation in chronic myelogenous leukaemia are not associated with JAK2 V617F or calreticulin mutations.
Turakhia SK; Murugesan G; Cotta CV; Theil KS
J Clin Pathol; 2016 Aug; 69(8):713-9. PubMed ID: 26754830
[TBL] [Abstract][Full Text] [Related]
11. Composite chronic myeloid leukemia and essential thrombocythemia with BCR-ABL1 fusion and CALR mutation.
Xia D; Hsi ED; Dal Cin P; Hasserjian RP
Am J Hematol; 2019 Apr; 94(4):504-505. PubMed ID: 30105753
[No Abstract] [Full Text] [Related]
12. Atypical myeloproliferative neoplasm with concurrent BCR-ABL1 fusion and CALR mutation: A case report and literature review.
Liu C; Hu R; Du Z; Abecasis M; Wang C
Medicine (Baltimore); 2020 Jan; 99(5):e18811. PubMed ID: 32000382
[TBL] [Abstract][Full Text] [Related]
13. A case of double positive myeloproliferative neoplasm: A diagnostic and therapeutic challenge.
Shaikh AB; Aribandi A; Gupta A; Subramanian SK; Goyal M
Indian J Pathol Microbiol; 2021; 64(4):820-823. PubMed ID: 34673614
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and whole exome/transcriptome sequencing of coexisting chronic myeloid leukemia and myelofibrosis.
Kandarpa M; Wu YM; Robinson D; Burke PW; Chinnaiyan AM; Talpaz M
Am J Hematol; 2017 Jun; 92(6):555-561. PubMed ID: 28335073
[TBL] [Abstract][Full Text] [Related]
15. [A case of chronic myeloid leukemia with positive CALR gene].
Han Y; Song Y; Wang Y; Chai Y; Zeng PY; Yue LL; Wu CY
Zhonghua Xue Ye Xue Za Zhi; 2020 Oct; 41(10):872. PubMed ID: 33190451
[No Abstract] [Full Text] [Related]
16. [BCR-ABL1-positive chronic myeloid leukemia emerging in a patient with secondary myelofibrosis harboring the JAK2-V617F mutation].
Amemiya A; Ito Y; Ishibashi Y; Saito Y; Katagiri S; Suguro T; Asano M; Yoshizawa S; Akahane D; Tanaka Y; Fujimoto H; Okabe S; Gotoh M; Tauchi T; Ohyashiki K
Rinsho Ketsueki; 2017; 58(4):298-302. PubMed ID: 28484156
[TBL] [Abstract][Full Text] [Related]
17. Emergence of therapy-unrelated CML on a background of BCR-ABL-negative JAK2V617F-positive chronic idiopathic myelofibrosis.
Jallades L; Hayette S; Tigaud I; Johnston A; Coiffier B; Magaud JP; Ffrench M
Leuk Res; 2008 Oct; 32(10):1608-10. PubMed ID: 18448166
[TBL] [Abstract][Full Text] [Related]
18. Chronic myeloid leukemia, BCR-ABL1-positive with CALR and MPL mutations.
Klairmont MM; Cheng J; Schwartzberg L; Ho HH; Gradowski JF
Int J Lab Hematol; 2018 Jun; 40(3):e41-e42. PubMed ID: 29508536
[No Abstract] [Full Text] [Related]
19. Chronic Myeloid Leukemia With Rare Variant b2a3 (e13a3) BCR-ABL1 Fusion.
Ha J; Cheong JW; Shin S; Lee ST; Choi JR
Ann Lab Med; 2016 May; 36(3):287-9. PubMed ID: 26915625
[No Abstract] [Full Text] [Related]
20. BCR-ABL1 mutation screening in chronic myeloid leukaemia: is next now?
Soverini S; Martelli M; Bavaro L
Lancet Haematol; 2019 May; 6(5):e236-e237. PubMed ID: 31036315
[No Abstract] [Full Text] [Related]
[Next] [New Search]